2 results
Approved WMOCompleted
primaryTo assess the safety and tolerability of multiple, once-daily oral doses of RDN-929 over 28 days in healthy older adult subjects and early symptomatic AD subjects.secondaryTo assess the plasma and CSF pharmacokinetics (PK) of RDN-929 in…
Approved WMOCompleted
Primary Objective: The primary objective of the pilot study is to evaluate the feasibility and acute efficacy of irreversible electroporation for pulmonary vein antrum isolation in patients with atrial fibrillation:- Acute pulmonary vein isolation…